Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8453185 | Journal of Bone Oncology | 2017 | 13 Pages |
Abstract
Denosumab was more effective than ZA in reducing the incidence of SRE in patients with bone metastases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zhicai Zhang, Feifei Pu, Zengwu Shao,